We apply the latest science to create, test, and scale solutions to address the most intractable problems in cancer care delivery.
Our Initiatives
We are worldwide experts in employing financial and non-financial interventions to nudge patient and clinician behavior in cancer care, informed by lessons from health economics and behavioral economics.
This study examined whether sending take-at-home FIT kits directly to patients’ homes would increase colorectal cancer screening rates among those for whom rates tend to be lower: people who are uninsured, low income, and/or members of racial and ethnic minority groups.
This pilot study addresses the low implementation rate of annual lung cancer screenings (LCS) in the United States, and examines the feasibility of using direct patient outreach and telemedicine referral to increase LCS counseling and uptake among screening-eligible patients who wish to be screened.
The RadComp Study, short for Radiotherapy Comparative Effectiveness, is a clinical study comparing two FDA approved radiation therapies — PHoton Therapy vs. PRoton Therapy — for the treatment of breast cancer and enrolls at over 70 radiation therapy practice sites nationwide.
Providing clinicians with patient-reported symptoms and remotely-monitored functional status will help clinicians better identify palliative care needs and increase rates of documented Serious Illness Conversations.
By combining innovations from behavioral economics and machine learning with highly accessible text-messaging platforms, this initiative has the potential not only to identify scalable, patient-targeted strategies for improving adherence to oral therapies, but also to transform the way cancer care is delivered and implemented.